stockrowNeurocrine Biosciences, Inc. (NBIX) vs United Therapeutics Corporation (UTHR)
- Neurocrine Biosciences, Inc. NBIX 160.47 −3.36%
- United Therapeutics Corporation UTHR 564.88 −7.17%
Neurocrine Biosciences, Inc. and United Therapeutics Corporation are both Drug Manufacturers Specialty & Generic companies. United Therapeutics Corporation is the larger, with a market value of $24.3B against $16.2B — 1.5× the size. United Therapeutics Corporation trades at the lower P/E: 19.7× against 23.0×. Neurocrine Biosciences, Inc. grew revenue faster over the last twelve months: 38.0% against 1.89%. United Therapeutics Corporation has the higher net margin (38.6% vs 19.0%) and the higher return on invested capital (30.1% vs 17.7%). Across the 21 metrics below, Neurocrine Biosciences, Inc. leads on 11 and United Therapeutics Corporation on 10.
Valuation
Profitability
| Metric | NBIX | UTHR | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 97.75% | 86.34% | 53.51% |
| Operating margin | 23.96% | 41.45% | 0.00% |
| Net margin | 18.98% | 38.61% | (2.45%) |
| Free cash flow margin | 28.09% | 27.21% | 0.00% |
| Return on equity | 20.41% | 19.13% | (0.80%) |
| Return on assets | 14.20% | 17.11% | (1.67%) |
| Return on invested capital | 17.65% | 30.13% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack